Walgreens
Track in portfolio
Price chart
Description
Company and Business Model
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. Its core products include prescription medications, health and wellness products, and retail pharmacy services. Major business segments consist of Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The primary revenue sources are retail sales of pharmaceuticals and health products, along with pharmacy services.
Investment Profile
The investment profile of Walgreens is more aligned with value investors, given its current stock performance and market position. The company may appeal to those seeking stability rather than aggressive growth, as it faces challenges in profitability. The stock is suitable for medium to long-term horizons, with moderate liquidity.
Fundamental metrics (experimental) Updated: 2026-07-24
- EPS (TTM) — earnings per share for the last 12 months, $
- -7.29
- Revenue QoQ — quarter-over-quarter revenue growth
- 1.0%
- EPS surprise
- 44.4%
- 20d volatility
- 0.0%
- last ex-date
- 2024-11-18
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-09 | Hold | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-06-01 | Sell | Hold | Weak fundamentals and high risk limit upside potential. |
| 2026-05-08 | — | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-05-08 | Hold | Hold | Компания показывает умеренный рост за последние месяцы, но отрицательный EPS и высокая волатильность указывают на значительные риски. Рекомендуется удерживать акции до более ясных сигналов о восстановлении. |
News Page 1 of 1
Nothing yet